Targeting tumor hypoxia in nasopharyngeal carcinoma

Bo Hong, Vivian Wai Yan Lui, Masumi Hashiguchi, Edwin Pun Hui, Anthony Tak Cheung Chan

Research output: Contribution to journalReview articlepeer-review

47 Scopus citations


Background Nasopharyngeal carcinoma (NPC) is an endemic head and neck cancer in Southeast Asia. Although concurrent chemoradiotherapy generally results in good clinical response for early diseases, posttreatment relapse and distant metastasis are major causes for NPC deaths. There is an urgent need for more effective therapies for advanced NPC. Recent studies have demonstrated tumor hypoxia can be a therapeutic target in NPC. Methods A Medline review of articles published on clinical and preclinical studies targeting tumor hypoxia was performed. Results Studies published to date showed that tumor hypoxia is common in NPC and it is associated with disease progression and resistance to therapy. Several mechanisms have been proposed on the role of tumor hypoxia in NPC cell survival, angiogenesis, and metabolism. Studies reported by us and by others have demonstrated the therapeutic potential of targeting tumor hypoxia in NPC. Conclusions Cumulative studies indicate that targeting tumor hypoxia could be an effective approach for NPC treatment.

Original languageEnglish (US)
Pages (from-to)133-145
Number of pages13
JournalHead and Neck
Issue number1
StatePublished - Jan 2013
Externally publishedYes


  • HIF-1α
  • hypoxia
  • mechanism for carcinogenesis
  • nasopharyngeal cancer (NPC)
  • targeted therapy

ASJC Scopus subject areas

  • Otorhinolaryngology


Dive into the research topics of 'Targeting tumor hypoxia in nasopharyngeal carcinoma'. Together they form a unique fingerprint.

Cite this